文献速递脑血管病外科神经重症

星状神经节阻滞降低蛛网膜下腔出血后大脑中动脉血流速度:潜在的血管痉挛治疗?

Decrease of blood flow velocity in the middle cerebral artery after stellate ganglion block following aneurysmal subarachnoid hemorrhage: a potential vasospasm treatment?
PubMed 文献 · J Neurosurg · 2019-08-09

本研究回顾性分析2013-2017年37例动脉瘤性蛛网膜下腔出血后顽固性脑血管痉挛患者,在最大标准治疗基础上行星状神经节阻滞(SGB),用经颅多普勒监测血流速度变化。结果显示首次SGB后2小时80.5%患者同侧大脑中动脉血流速度从平均160.3±28.2 cm/sec降至127.5±34.3 cm/sec(p<0.001),24小时仍有63.4%患者下降至137.2±38.2 cm/sec(p=0.007),对侧无降低,无重大并发症。

要点

  • SGB后2小时80.5%患者同侧MCA血流速度显著下降。
  • SGB后24小时63.4%患者血流速度仍低于基线。
  • 对侧MCA血流速度未受SGB影响。

核心结论

  • SGB可显著降低aSAH后同侧大脑中动脉血流速度,效果可持续超过24小时且无重大并发症。

研究设计与样本

  • 回顾性研究,纳入2013-2017年37例aSAH后顽固性CV患者,共接受76次SGB。

主要发现

  • 首次SGB后2小时,80.5%患者同侧CBFV从平均160.3±28.2 cm/sec降至127.5±34.3 cm/sec(p<0.001)。
  • 首次SGB后24小时,63.4%患者同侧CBFV降至137.2±38.2 cm/sec(p=0.007)。
  • 后续SGB也显示类似显著效果。
  • 加用可乐定对SGB起效时间或持续时间无显著影响。
  • 对侧MCA血流速度未因SGB降低。

关键数值与推荐

  • 纳入标准:aSAH后CBFV≥120 cm/sec且存在局灶性神经功能缺损或意识下降,尽管已接受药物治疗和血压管理。
  • SGB在CBFV最高侧进行,使用0.2%罗哌卡因8-10 ml。

临床怎么用

  • 对于aSAH后顽固性CV患者,可考虑在CBFV最高侧行SGB以降低同侧血流速度。

局限性

  • 回顾性研究设计,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cerebral vasospasm (CV) is a delayed, sustained contraction of the cerebral arteries that tends to occur 3-14 days after aneurysmal subarachnoid hemorrhage (aSAH) from a ruptured aneurysm. Vasospasm potentially leads to delayed cerebral ischemia, and despite medical treatment, 1 of 3 patients suffer a persistent neurological deficit. Bedside transcranial Doppler (TCD) ultrasonography is used to indirectly detect CV through recognition of an increase in cerebral blood flow velocity (CBFV). The present study aimed to use TCD ultrasonography to monitor how CBFV changes on both the ipsi- and contralateral sides of the brain in the first 24 hours after patients have received a stellate ganglion block (SGB) to treat CV that persists despite maximum standard therapy. METHODS: The data were culled from records of patients treated between 2013 and 2017. Patients were included if an SGB was administered following aSAH, whose CBFV was ≥ 120 cm/sec and who had either a focal neurological deficit or reduced consciousness despite having received medical treatment and blood pressure management. The SGB was performed on the side where the highest CBFV had been recorded with 8-10 ml ropivacaine 0.2%. The patient's CBFV was reassessed after 2 and 24 hours. RESULTS: Thirty-seven patients (male/female ratio 18:19), age 17-70 years (mean age 49.9 ± 11.1), who harbored 13 clipped and 22 coiled aneurysms (1 patient received both a coil and a clip, and 3 patients had 3 untreated aneurysms) had at least one SGB. Patients received up to 4 SGBs, and thus the study comprised a total of 76 SGBs.After the first SGB, CBFV decreased in 80.5% of patients after 2 hours, from a mean of 160.3 ± 28.2 cm/sec to 127.5 ± 34.3 cm/sec (p < 0.001), and it further decreased in 63.4% after 24 hours to 137.2 ± 38.2 cm/sec (p = 0.007). A similar significant effect was found for the subsequent SGB. Adding clonidine showed no significant effect on either the onset or the duration of the SGB. Contralateral middle cerebral artery (MCA) blood flow was not reduced by the SGB. CONCLUSIONS: To the authors' knowledge, this is the largest study on the effects of administering an SGB to aSAH patients after aneurysm rupture. The data showed a significant reduction in ipsilateral CBFV (MCA 20.5%) after SGB, lasting in about two-thirds of cases for over 24 hours with no major complications resulting from the SGB.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wendel C, Scheibe R, Wagner S, et al. Decrease of blood flow velocity in the middle cerebral artery after stellate ganglion block following aneurysmal subarachnoid hemorrhage: a potential vasospasm treatment? J Neurosurg. 2019. PMID: 31398704. doi:10.3171/2019.5.JNS182890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。